Clinical Trial Update: Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tranexamic acid to sublingual misoprostol for reducing blood loss during elective cesarean sections in high-risk postpartum hemorrhage p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | Phase 2 | Status: COMPLETED